Best Biotech Stocks to Buy Now (2024)Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IFRX | INFLARX NV | $81.26M | $1.38 | $8.00 | 479.71% | Buy | 1 | 799.80% | N/A | N/A | N/A | ||||
| LQDA | LIQUIDIA CORP | $972.40M | $12.79 | $21.60 | 68.88% | Buy | 5 | 118.22% | N/A | N/A | N/A | ||||
| ATAI | ATAI LIFE SCIENCES NV | $340.35M | $2.05 | $10.50 | 412.20% | Strong Buy | 2 | 68.42% | N/A | N/A | N/A | ||||
| GLMD | GALMED PHARMACEUTICALS LTD | $1.95M | $0.39 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| AUPH | AURINIA PHARMACEUTICALS INC | $729.40M | $5.10 | $10.33 | 102.61% | Strong Buy | 3 | 30.55% | N/A | N/A | N/A | ||||
| BEAM | BEAM THERAPEUTICS INC | $1.89B | $23.13 | $42.29 | 82.82% | Buy | 7 | -50.54% | N/A | N/A | N/A | ||||
| CASI | CASI PHARMACEUTICALS INC | $37.39M | $2.80 | $12.00 | 329.34% | Buy | 1 | 61.96% | N/A | N/A | N/A | ||||
| NRBO | NEUROBO PHARMACEUTICALS INC | $18.54M | $3.78 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| BLUE | BLUEBIRD BIO INC | $98.40M | $0.90 | $5.71 | 534.78% | Hold | 8 | 150.43% | N/A | N/A | N/A | ||||
| HOTH | HOTH THERAPEUTICS INC | $5.33M | $1.21 | $5.50 | 354.55% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| MTEM | MOLECULAR TEMPLATES INC | $8.98M | $1.67 | N/A | N/A | N/A | N/A | -47.20% | N/A | N/A | N/A | ||||
| ARVN | ARVINAS INC | $2.23B | $32.82 | $59.31 | 80.71% | Strong Buy | 13 | 59.11% | N/A | N/A | N/A | ||||
| MESO | MESOBLAST LTD | $761.10M | $7.50 | N/A | N/A | N/A | N/A | 54.19% | N/A | N/A | N/A | ||||
| CRBU | CARIBOU BIOSCIENCES INC | $340.49M | $3.77 | $21.50 | 470.29% | Buy | 2 | -26.72% | N/A | N/A | N/A | ||||
| YMAB | Y-MABS THERAPEUTICS INC | $750.78M | $17.15 | $24.33 | 41.88% | Strong Buy | 3 | 14.09% | N/A | N/A | N/A | ||||
| LIFE | ATYR PHARMA INC | $111.11M | $1.61 | $25.50 | 1,483.85% | Buy | 2 | 432.78% | N/A | N/A | N/A | ||||
| CUE | CUE BIOPHARMA INC | $103.61M | $2.13 | $8.00 | 275.59% | Strong Buy | 4 | 62.69% | N/A | N/A | N/A | ||||
| PGEN | PRECIGEN INC | $353.47M | $1.42 | $10.00 | 604.23% | Buy | 2 | 198.74% | N/A | N/A | N/A | ||||
| CCCC | C4 THERAPEUTICS INC | $462.37M | $6.74 | $9.00 | 33.53% | Buy | 3 | 112.66% | N/A | N/A | N/A | ||||
| ARDX | ARDELYX INC | $2.04B | $8.72 | $14.60 | 67.43% | Strong Buy | 5 | 53.03% | N/A | N/A | N/A | ||||
| IKNA | IKENA ONCOLOGY INC | $63.70M | $1.32 | $9.50 | 619.70% | Buy | 2 | 48.45% | N/A | N/A | N/A | ||||
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC | $5.96M | $4.40 | N/A | N/A | N/A | N/A | 1,601.51% | N/A | N/A | N/A | ||||
| LYRA | LYRA THERAPEUTICS INC | $245.69M | $4.03 | $11.50 | 185.36% | Strong Buy | 2 | 98.72% | N/A | N/A | N/A | ||||
| QTTB | Q32 BIO INC | $82.65M | $25.59 | $47.50 | 85.62% | Strong Buy | 2 | 341.21% | N/A | N/A | N/A | ||||
| ALLO | ALLOGENE THERAPEUTICS INC | $519.11M | $3.07 | $8.75 | 185.02% | Strong Buy | 4 | 352.37% | N/A | N/A | N/A | ||||
| MIST | MILESTONE PHARMACEUTICALS INC | $89.82M | $1.69 | $15.00 | 787.57% | Strong Buy | 2 | 402.59% | N/A | N/A | N/A | ||||
| PRTC | PURETECH HEALTH PLC | $773.99M | $28.47 | N/A | N/A | N/A | N/A | 170.78% | N/A | N/A | N/A | ||||
| XOMA | XOMA CORP | $288.09M | $24.78 | $57.00 | 130.02% | Buy | 2 | 89.59% | N/A | N/A | N/A | ||||
| NTLA | INTELLIA THERAPEUTICS INC | $2.27B | $23.60 | $59.75 | 153.18% | Buy | 8 | 45.90% | N/A | N/A | N/A | ||||
| PLUR | PLURI INC | $29.81M | $5.75 | N/A | N/A | N/A | N/A | 227.30% | N/A | N/A | N/A | ||||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $774.51M | $8.00 | $13.50 | 68.75% | Strong Buy | 4 | 94.05% | N/A | N/A | N/A | ||||
| DNLI | DENALI THERAPEUTICS INC | $2.39B | $17.14 | $44.67 | 160.60% | Strong Buy | 6 | -10.36% | N/A | N/A | N/A | ||||
| LYEL | LYELL IMMUNOPHARMA INC | $599.67M | $2.36 | $6.00 | 154.24% | Buy | 1 | 7,592.31% | N/A | -68.28% | -59.63% | ||||
| SPRC | SCISPARC LTD | $890.42k | $1.26 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| IMNM | IMMUNOME INC | $940.18M | $15.75 | $30.67 | 94.71% | Strong Buy | 3 | 45.81% | N/A | N/A | N/A | ||||
| KROS | KEROS THERAPEUTICS INC | $2.18B | $60.57 | $90.20 | 48.92% | Strong Buy | 5 | 768.53% | N/A | N/A | N/A | ||||
| GLYC | GLYCOMIMETICS INC | $117.94M | $1.83 | $10.00 | 446.45% | Buy | 2 | 1,773.37% | N/A | N/A | N/A | ||||
| INO | INOVIO PHARMACEUTICALS INC | $282.78M | $12.10 | $21.00 | 73.55% | Buy | 3 | 522.90% | N/A | N/A | N/A | ||||
| MRNS | MARINUS PHARMACEUTICALS INC | $82.51M | $1.51 | $13.17 | 771.99% | Buy | 6 | 70.93% | N/A | N/A | N/A | ||||
| ABCL | ABCELLERA BIOLOGICS INC | $1.18B | $4.03 | $11.50 | 185.36% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| OVID | OVID THERAPEUTICS INC | $216.37M | $3.06 | $9.25 | 202.29% | Strong Buy | 4 | 307.28% | N/A | N/A | N/A | ||||
| EDIT | EDITAS MEDICINE INC | $463.88M | $5.67 | $14.00 | 146.91% | Buy | 4 | 11.05% | N/A | N/A | N/A | ||||
| COCP | COCRYSTAL PHARMA INC | $16.58M | $1.63 | $10.00 | 513.50% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| PALI | PALISADE BIO INC | $6.59M | $7.74 | $22.50 | 190.70% | Strong Buy | 1 | N/A | N/A | N/A | N/A | ||||
| CRNX | CRINETICS PHARMACEUTICALS INC | $3.28B | $47.20 | $57.89 | 22.65% | Strong Buy | 9 | 174.31% | N/A | N/A | N/A | ||||
| ALEC | ALECTOR INC | $516.09M | $5.39 | $19.25 | 257.14% | Strong Buy | 4 | 13.52% | N/A | N/A | N/A | ||||
| ALPN | ALPINE IMMUNE SCIENCES INC | $4.23B | $64.60 | $55.86 | -13.53% | Buy | 7 | -10.79% | N/A | N/A | N/A | ||||
| STTK | SHATTUCK LABS INC | $512.60M | $10.78 | $20.00 | 85.53% | Buy | 2 | 292.96% | N/A | N/A | N/A | ||||
| GERN | GERON CORP | $2.33B | $3.93 | $6.10 | 55.22% | Buy | 5 | 841.22% | N/A | N/A | N/A | ||||
| GBIO | GENERATION BIO CO | $210.73M | $3.17 | $7.50 | 136.59% | Buy | 2 | 16.09% | N/A | N/A | N/A | ||||
| MGNX | MACROGENICS INC | $978.31M | $15.67 | $21.56 | 37.56% | Strong Buy | 9 | 45.96% | N/A | N/A | N/A | ||||
| PPBT | PURPLE BIOTECH LTD | $10.51M | $0.53 | $10.50 | 1,881.13% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| ABSI | ABSCI CORP | $572.95M | $5.08 | $9.25 | 82.09% | Strong Buy | 4 | 110.39% | N/A | N/A | N/A | ||||
| LUMO | LUMOS PHARMA INC | $24.00M | $2.96 | $22.00 | 643.24% | Buy | 2 | 180.56% | N/A | N/A | N/A | ||||
| KYMR | KYMERA THERAPEUTICS INC | $2.29B | $37.40 | $43.00 | 14.97% | Buy | 8 | -2.00% | N/A | N/A | N/A | ||||
| IMAB | I-MAB | $142.11M | $1.76 | $8.00 | 354.55% | Strong Buy | 3 | -7.77% | N/A | N/A | N/A | ||||
| MRNA | MODERNA INC | $47.90B | $125.00 | $117.50 | -6.00% | Buy | 6 | 10.80% | N/A | N/A | N/A | ||||
| QURE | UNIQURE NV | $224.36M | $4.69 | $17.80 | 279.53% | Buy | 5 | 76.45% | N/A | N/A | N/A | ||||
| CVKD | CADRENAL THERAPEUTICS INC | $7.84M | $0.49 | $3.50 | 614.29% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| SXTP | 60 DEGREES PHARMACEUTICALS INC | $2.43M | $0.21 | N/A | N/A | N/A | N/A | 125.84% | N/A | N/A | N/A | ||||
| NGNE | NEUROGENE INC | $470.80M | $36.63 | $44.00 | 20.12% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| BPMC | BLUEPRINT MEDICINES CORP | $6.71B | $107.19 | $110.00 | 2.62% | Buy | 10 | 39.12% | N/A | N/A | N/A | ||||
| ATOS | ATOSSA THERAPEUTICS INC | $208.00M | $1.66 | $4.00 | 140.96% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| EVGN | EVOGENE LTD | $35.92M | $0.71 | N/A | N/A | N/A | N/A | 519.33% | N/A | -138.50% | -32.67% | ||||
| ELVN | ENLIVEN THERAPEUTICS INC | $936.52M | $22.65 | $34.00 | 50.11% | Strong Buy | 1 | N/A | N/A | N/A | N/A | ||||
| DTIL | PRECISION BIOSCIENCES INC | $72.76M | $10.52 | $39.50 | 275.48% | Strong Buy | 2 | -9.49% | N/A | N/A | N/A | ||||
| CLDX | CELLDEX THERAPEUTICS INC | $2.38B | $42.56 | $66.00 | 55.08% | Strong Buy | 4 | -2.54% | N/A | N/A | N/A | ||||
| DMAC | DIAMEDICA THERAPEUTICS INC | $113.87M | $3.00 | $7.00 | 133.33% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| SVRA | SAVARA INC | $649.99M | $4.71 | $9.25 | 96.60% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| TCRX | TSCAN THERAPEUTICS INC | $409.87M | $8.56 | $11.33 | 32.39% | Strong Buy | 3 | -4.23% | N/A | N/A | N/A | ||||
| AVXL | ANAVEX LIFE SCIENCES CORP | $316.13M | $3.85 | $40.00 | 938.96% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| TBPH | THERAVANCE BIOPHARMA INC | $455.64M | $9.46 | $21.00 | 121.99% | Strong Buy | 1 | 33.00% | N/A | N/A | N/A | ||||
| DNTH | DIANTHUS THERAPEUTICS INC | $757.15M | $25.80 | $41.75 | 61.82% | Strong Buy | 4 | -0.85% | N/A | N/A | N/A | ||||
| NTBL | NOTABLE LABS LTD | $8.57M | $0.95 | $8.00 | 742.11% | Strong Buy | 2 | 24.62% | N/A | N/A | N/A | ||||
| CRDF | CARDIFF ONCOLOGY INC | $157.43M | $3.52 | $10.50 | 198.30% | Strong Buy | 2 | -37.60% | N/A | N/A | N/A | ||||
| TTNP | TITAN PHARMACEUTICALS INC | $6.29M | $6.88 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| MOLN | MOLECULAR PARTNERS AG | $130.76M | $3.98 | $4.50 | 13.07% | Hold | 1 | -13.73% | N/A | N/A | N/A | ||||
| LABP | LANDOS BIOPHARMA INC | $69.30M | $22.24 | $20.42 | -8.16% | Hold | 1 | N/A | N/A | N/A | N/A | ||||
| PMCB | PHARMACYTE BIOTECH INC | $17.86M | $2.11 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $1.31B | $26.38 | $53.83 | 104.07% | Strong Buy | 6 | -16.91% | N/A | N/A | N/A | ||||
| LSTA | LISATA THERAPEUTICS INC | $23.68M | $2.85 | $15.00 | 426.32% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| TRVI | TREVI THERAPEUTICS INC | $208.26M | $3.02 | $8.50 | 181.46% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| BOLT | BOLT BIOTHERAPEUTICS INC | $41.94M | $1.10 | $8.00 | 627.27% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| ETNB | 89BIO INC | $862.08M | $9.22 | $28.20 | 205.86% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| TVTX | TRAVERE THERAPEUTICS INC | $476.38M | $6.26 | $12.20 | 94.89% | Buy | 5 | 42.73% | N/A | N/A | N/A | ||||
| AKRO | AKERO THERAPEUTICS INC | $1.11B | $19.66 | $40.67 | 106.85% | Buy | 3 | N/A | N/A | N/A | N/A | ||||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $44.88M | $1.79 | $4.00 | 123.46% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| RIGL | RIGEL PHARMACEUTICALS INC | $210.45M | $1.20 | $5.81 | 384.42% | Buy | 4 | 23.54% | N/A | N/A | N/A | ||||
| ATXS | ASTRIA THERAPEUTICS INC | $524.32M | $9.55 | $21.25 | 122.51% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| DNA | GINKGO BIOWORKS HOLDINGS INC | $2.06B | $0.96 | $2.20 | 130.37% | Hold | 3 | 21.73% | N/A | N/A | N/A | ||||
| TERN | TERNS PHARMACEUTICALS INC | $351.71M | $5.44 | $13.50 | 148.16% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| ABIO | ARCA BIOPHARMA INC | $47.29M | $3.26 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| IOBT | IO BIOTECH INC | $97.50M | $1.48 | $8.00 | 440.54% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| CYCN | CYCLERION THERAPEUTICS INC | $8.01M | $2.96 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| CABA | CABALETTA BIO INC | $597.71M | $12.39 | $34.33 | 177.10% | Strong Buy | 6 | N/A | N/A | N/A | N/A | ||||
| RXRX | RECURSION PHARMACEUTICALS INC | $2.07B | $8.84 | $14.33 | 62.14% | Buy | 3 | 23.96% | N/A | N/A | N/A | ||||
| MNKD | MANNKIND CORP | $1.19B | $4.39 | $7.00 | 59.45% | Strong Buy | 2 | 19.90% | N/A | N/A | N/A | ||||
| PHAR | PHARMING GROUP NV | $671.07M | $10.00 | $37.00 | 270.00% | Buy | 1 | 12.71% | N/A | N/A | N/A | ||||
| URGN | UROGEN PHARMA LTD | $487.95M | $14.30 | $44.00 | 207.69% | Buy | 2 | 48.09% | N/A | N/A | N/A | ||||
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | $436.73M | $3.01 | $6.00 | 99.34% | Strong Buy | 4 | 15.87% | N/A | N/A | N/A |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.